Suppr超能文献

新冠疫情期间美国堕胎服务的可及性:美国堕胎机构全国普查结果

Abortion service availability during the COVID-19 pandemic: Results from a national census of abortion facilities in the U.S.

作者信息

Kaller Shelly, Muñoz M G Isabel, Sharma Subeksha, Tayel Salma, Ahlbach Chris, Cook Clara, Upadhyay Ushma D

机构信息

Advancing New Standards in Reproductive Health (ANSIRH), Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, Oakland, CA, United States.

University of California, Berkeley, School of Public Health, CA, United States.

出版信息

Contracept X. 2021;3:100067. doi: 10.1016/j.conx.2021.100067. Epub 2021 Jul 6.

Abstract

OBJECTIVE

This study assessed the impact of COVID-19 on abortion services in all 50 United States states and the District of Columbia.

STUDY DESIGN

ANSIRH's Abortion Facility Database is a systematic collection of data on all publicly-advertising abortion facilities in the United States, updated annually through online searches and mystery shopper phone calls. Research staff updated the database in May-August 2020, assessing the number of facilities that closed, limited or stopped providing abortions, and provided telehealth options in summer 2020 due to COVID-19.  We describe these changes using frequencies and highlighting themes and examples from coded qualitative data.

RESULTS

Located primarily in the South and Midwest, 24 of 751 facilities that were open in 2019 temporarily closed due to the pandemic, with 9 still closed by August 2020. Other facilities described suspending abortions, referring abortion patients to other facilities, or limiting services to medication abortion. While most facilities required in-person visits for reasons like state abortion restrictions, 22% ( = 150) offered phone or telehealth consultations, no-test visits, or medication abortion by mail to reduce or eliminate patient time in the clinic. Some facilities used creative strategies to reduce COVID-19 risk like allowing patients to wait for visits in their cars or offering drive-through medication pick-up.

CONCLUSIONS

The COVID-19 pandemic caused several disruptions to abortion service availability, including closures. To reduce in-person visit time, some clinics shifted to offering medication abortion (versus procedural) or telehealth. While the pandemic and abortion restrictions increased barriers to abortion provision, facilities were resilient and adapted to provide safe care for their patients.

IMPLICATIONS

Barriers to abortion access were exacerbated during the COVID-19 pandemic, particularly in areas of the country with more restrictive policies toward abortion. Telehealth care protocols offered by many abortion facilities provide an option to reduce or eliminate in-person visits.

摘要

目的

本研究评估了新型冠状病毒肺炎(COVID-19)对美国所有50个州及哥伦比亚特区堕胎服务的影响。

研究设计

美国生殖健康与政策研究所(ANSIRH)的堕胎机构数据库系统收集了美国所有公开宣传的堕胎机构的数据,每年通过在线搜索和暗访者电话进行更新。研究人员在2020年5月至8月更新了该数据库,评估了因COVID-19而关闭、限制或停止提供堕胎服务的机构数量,以及2020年夏季提供远程医疗服务的情况。我们使用频率描述这些变化,并突出编码定性数据中的主题和示例。

结果

主要位于南部和中西部地区,2019年营业的751家机构中有24家因疫情暂时关闭,到2020年8月仍有9家关闭。其他机构表示暂停堕胎服务,将堕胎患者转介至其他机构,或仅提供药物流产服务。虽然大多数机构因州堕胎限制等原因要求患者亲自就诊,但22%(n = 150)的机构提供电话或远程医疗咨询、免检查就诊或邮寄药物流产服务,以减少或消除患者在诊所的停留时间。一些机构采用了创新策略来降低COVID-19风险,比如允许患者在车内等待就诊或提供得来速式药物领取服务。

结论

COVID-19大流行导致堕胎服务的可及性出现了一些中断,包括机构关闭。为了减少亲自就诊时间,一些诊所转而提供药物流产(而非手术流产)或远程医疗服务。虽然大流行和堕胎限制增加了堕胎服务的障碍,但各机构具有韧性并做出了调整,为患者提供安全的护理。

启示

在COVID-19大流行期间,堕胎服务的障碍加剧,尤其是在对堕胎政策限制较多的地区。许多堕胎机构提供的远程医疗护理方案为减少或消除亲自就诊提供了一种选择。

相似文献

3
Adoption of no-test and telehealth medication abortion care among independent abortion providers in response to COVID-19.
Contracept X. 2020 Nov 21;2:100049. doi: 10.1016/j.conx.2020.100049. eCollection 2020.
4
Factors associated with successful implementation of telehealth abortion in 4 United States clinical practice settings.
Contraception. 2021 Jul;104(1):82-91. doi: 10.1016/j.contraception.2021.04.021. Epub 2021 Apr 29.
5
Pricing of medication abortion in the United States, 2021-2023.
Perspect Sex Reprod Health. 2024 Sep;56(3):282-294. doi: 10.1111/psrh.12280. Epub 2024 Jul 2.
6
Abortion service provision in South Asia: A comparative study of four countries.
Contraception. 2020 Sep;102(3):210-219. doi: 10.1016/j.contraception.2020.05.015. Epub 2020 May 29.
8
Changes to medication abortion clinical practices in response to the COVID-19 pandemic.
Contraception. 2021 Jul;104(1):77-81. doi: 10.1016/j.contraception.2021.04.010. Epub 2021 Apr 21.
9
The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic.
Fam Pract. 2021 Aug 27;38(Suppl 1):i30-i36. doi: 10.1093/fampra/cmab083.

引用本文的文献

3
Pricing of medication abortion in the United States, 2021-2023.
Perspect Sex Reprod Health. 2024 Sep;56(3):282-294. doi: 10.1111/psrh.12280. Epub 2024 Jul 2.
4
"I'm going to be forced to have a baby": A study of COVID-19 abortion experiences on Reddit.
Perspect Sex Reprod Health. 2023 Jun;55(2):86-93. doi: 10.1363/psrh.12225. Epub 2023 May 11.
5
Abortion services during the COVID-19 pandemic: a systematic review.
Reprod Health. 2023 Apr 13;20(1):61. doi: 10.1186/s12978-023-01582-3.
6
Abortion Surveillance - United States, 2020.
MMWR Surveill Summ. 2022 Nov 25;71(10):1-27. doi: 10.15585/mmwr.ss7110a1.
7
Abortion as an Essential Health Service in Latin America During the COVID-19 Pandemic.
Front Glob Womens Health. 2022 Aug 1;3:898754. doi: 10.3389/fgwh.2022.898754. eCollection 2022.
8
Comprehension of an Over-the-Counter Drug Facts Label Prototype for a Mifepristone and Misoprostol Medication Abortion Product.
Obstet Gynecol. 2022 Jun 1;139(6):1111-1122. doi: 10.1097/AOG.0000000000004757. Epub 2022 May 2.

本文引用的文献

2
Changes in Abortion in Texas Following an Executive Order Ban During the Coronavirus Pandemic.
JAMA. 2021 Feb 16;325(7):691-693. doi: 10.1001/jama.2020.24096.
3
Adoption of no-test and telehealth medication abortion care among independent abortion providers in response to COVID-19.
Contracept X. 2020 Nov 21;2:100049. doi: 10.1016/j.conx.2020.100049. eCollection 2020.
4
COVID-19 and Independent Abortion Providers: Findings from a Rapid-Response Survey.
Perspect Sex Reprod Health. 2020 Dec;52(4):217-225. doi: 10.1363/psrh.12163. Epub 2020 Dec 9.
5
Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin, Number 225.
Obstet Gynecol. 2020 Oct;136(4):e31-e47. doi: 10.1097/AOG.0000000000004082.
6
COVID-19 Abortion Bans and Their Implications for Public Health.
Perspect Sex Reprod Health. 2020 Jul;52(2):65-68. doi: 10.1363/psrh.12139. Epub 2020 Jun 18.
7
Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond.
Contraception. 2020 Jun;101(6):361-366. doi: 10.1016/j.contraception.2020.04.005. Epub 2020 Apr 16.
9
Barriers to Abortion Care and Their Consequences For Patients Traveling for Services: Qualitative Findings from Two States.
Perspect Sex Reprod Health. 2017 Jun;49(2):95-102. doi: 10.1363/psrh.12024. Epub 2017 Apr 10.
10
Sixteen Years of Overregulation: Time to Unburden Mifeprex.
N Engl J Med. 2017 Feb 23;376(8):790-794. doi: 10.1056/NEJMsb1612526.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验